Regulatory News
Tuesday, December 20, 2016
BRIEF-Kiadis Pharma provides update on second dose trial with ATIR101
* Kiadis Pharma provides update on second dose trial
(CR-AIR-008) with ATIR101
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment